Quantinno Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
JT
CAM
Quantinno Capital Management's LGND Position: Q2 2026 in Review
Quantinno Capital Management increased its Ligand Pharmaceuticals (LGND) stake by 95% in Q2 2026, buying an estimated $1.39M and bringing the position to 12,124 shares worth $3.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1456.
Quantinno Capital Management first reported a position in LGND in Q3 2025 and has held it in 4 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Quantinno Capital Management held 12,124 shares of Ligand Pharmaceuticals worth $3.83M as of Q2 2026.
- Quantinno Capital Management bought 5,897 Ligand Pharmaceuticals shares in Q2 2026, an estimated $1.39M.
- Ligand Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1456 holding.
- Quantinno Capital Management first reported a position in Ligand Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.